Global Hematology Quality Controls Market Growth 2025-2031
Description
The global Hematology Quality Controls market size is predicted to grow from US$ 525 million in 2025 to US$ 763 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Hematology Quality Controls are specialized quality control substances used to monitor the stability of the detection process of blood analyzers (such as blood routine testing equipment) and evaluate the performance of the detection system. Its core goal is to ensure that the blood analyzer provides accurate, reliable, and reproducible test results for patient samples at different times, batches of reagents, or operating conditions. It is one of the core tools of the quality management system for blood testing laboratories.
United States market for Hematology Quality Controls is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Hematology Quality Controls is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Hematology Quality Controls is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Hematology Quality Controls players cover Bio-Rad, Streck, Thermo Fisher Scientific, Randox Laboratories, Sysmex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Hematology Quality Controls Industry Forecast” looks at past sales and reviews total world Hematology Quality Controls sales in 2024, providing a comprehensive analysis by region and market sector of projected Hematology Quality Controls sales for 2025 through 2031. With Hematology Quality Controls sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hematology Quality Controls industry.
This Insight Report provides a comprehensive analysis of the global Hematology Quality Controls landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hematology Quality Controls portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hematology Quality Controls market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hematology Quality Controls and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hematology Quality Controls.
This report presents a comprehensive overview, market shares, and growth opportunities of Hematology Quality Controls market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
High Level
Medium Level
Low Level
Segmentation by Application:
Hospital
Laboratory
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bio-Rad
Streck
Thermo Fisher Scientific
Randox Laboratories
Sysmex
Fortress Diagnostics
Bio-Techne
Diatron
Changchun DIRUI
Shenzhen Mindray
Sichuan ZCMT
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hematology Quality Controls market?
What factors are driving Hematology Quality Controls market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hematology Quality Controls market opportunities vary by end market size?
How does Hematology Quality Controls break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Hematology Quality Controls are specialized quality control substances used to monitor the stability of the detection process of blood analyzers (such as blood routine testing equipment) and evaluate the performance of the detection system. Its core goal is to ensure that the blood analyzer provides accurate, reliable, and reproducible test results for patient samples at different times, batches of reagents, or operating conditions. It is one of the core tools of the quality management system for blood testing laboratories.
United States market for Hematology Quality Controls is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Hematology Quality Controls is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Hematology Quality Controls is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Hematology Quality Controls players cover Bio-Rad, Streck, Thermo Fisher Scientific, Randox Laboratories, Sysmex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Hematology Quality Controls Industry Forecast” looks at past sales and reviews total world Hematology Quality Controls sales in 2024, providing a comprehensive analysis by region and market sector of projected Hematology Quality Controls sales for 2025 through 2031. With Hematology Quality Controls sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hematology Quality Controls industry.
This Insight Report provides a comprehensive analysis of the global Hematology Quality Controls landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hematology Quality Controls portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hematology Quality Controls market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hematology Quality Controls and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hematology Quality Controls.
This report presents a comprehensive overview, market shares, and growth opportunities of Hematology Quality Controls market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
High Level
Medium Level
Low Level
Segmentation by Application:
Hospital
Laboratory
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bio-Rad
Streck
Thermo Fisher Scientific
Randox Laboratories
Sysmex
Fortress Diagnostics
Bio-Techne
Diatron
Changchun DIRUI
Shenzhen Mindray
Sichuan ZCMT
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hematology Quality Controls market?
What factors are driving Hematology Quality Controls market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hematology Quality Controls market opportunities vary by end market size?
How does Hematology Quality Controls break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
116 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Hematology Quality Controls by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Hematology Quality Controls by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
